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Abstract
The socioeconomic and medical improvements of the last decades have led to a rel-
evant increase in the median age of worldwide population. Although numerous
studies described the impact of aging in different organs and the systemic vascula-
ture, relatively little is known about liver function and hepatic microcirculatory sta-
tus in the elderly. In this study, we aimed at characterizing the phenotype of the
aged liver in a rat model of healthy aging, particularly focusing on the microcircula-
tory function and the molecular status of each hepatic cell type in the sinusoid.
Moreover, major findings of the study were validated in young and aged human liv-
ers. Our results demonstrate that healthy aging is associated with hepatic and sinu-
soidal dysfunction, with elevated hepatic vascular resistance and increased portal
pressure. Underlying mechanisms of such hemodynamic disturbances included typi-
cal molecular changes in the cells of the hepatic sinusoid and deterioration in hepa-
tocyte function. In a specific manner, liver sinusoidal endothelial cells presented a
dysfunctional phenotype with diminished vasodilators synthesis, hepatic macro-
phages exhibited a proinflammatory state, while hepatic stellate cells spontaneously
displayed an activated profile. In an important way, major changes in sinusoidal
markers were confirmed in livers from aged humans. In conclusion, our study
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demonstrates for the first time that aging is accompanied by significant liver sinu-
soidal deregulation suggesting enhanced sinusoidal vulnerability to chronic or acute
injuries.
1 | INTRODUCTION
Societies in developed countries are getting older due to
the increase in life expectancy. Nowadays, 14% of European citi-
zens are aged over 65, and by 2030, they are expected to consti-
tute 23% (He, Goodkind, & Kowal, 2016). Therefore, the pace of
population aging represents an important healthcare and social
issue and it is therefore essential to understand the molecular
basis of aging to identify possible approaches for therapeutic
intervention.
The liver plays essential roles in metabolism, toxicants clearance,
regulation of inflammation, and molecule biosynthesis. To fulfill these
complex tasks, it requires an adequate microcirculation and a correct
coordinated function of all hepatic cell types (Arias et al., 2009).
Although it is well known that hepatocytes constitute the main cell
type contributing to the metabolic and synthetic capacities of the
liver, their function deeply depends on an efficient exchange of sub-
stances with the blood stream and a proper communication with
other hepatic cells.
Liver sinusoidal endothelial cells (LSEC), hepatic stellate cells
(HSC), and Kupffer cells (KC) are the major components of the hep-
atic sinusoid, which collaborate to maintain the integrity and func-
tionality of the unique liver microcirculatory system (Marrone, Shah,
& Gracia‐Sancho, 2016). LSEC are a very specialized fenestrated
endothelial cell forming the capillary bed of the sinusoids, being sep-
arated from hepatocytes through the space of Disse. HSC are vita-
min A storing cells located in the space of Disse, surrounding LSEC,
and represent the liver pericytes. At last, KC, the resident macro-
phages of the liver, are located at the luminal side of the endothelial
lining (Fernández‐Iglesias & Gracia‐Sancho, 2017; Friedman, 2008; Ju
& Tacke, 2016).
Previous studies characterized single variables in the liver during
aging and showed reduction in liver mass and hepatic blood flow,
partial loss of endothelial fenestration, and possibly activation of
HSC (Le Couteur et al., 2001; Vollmar, Pradarutti, Richter, & Menger,
2002). Nevertheless, studies analyzing in depth the hepatic sinusoid,
its cellular components, and the hepatic microcirculatory function in
aging are limited.
This study aimed at comprehensively characterizing the pheno-
type of the sinusoid in aged liver using a preclinical rat model of
healthy aging, particularly focusing on the microcirculatory function
and the molecular profile of each major liver cell type. In addition,
our study further compared these findings to the key cellular
modifications related to aging in livers from young and aged
humans.
2 | RESULTS
2.1 | Aged rat model: Baseline characteristics and
biochemical parameters
As shown in Table 1, aged rats (20 months old) presented signifi-
cantly increased body and liver weight compared to 3‐month young
rats, however, liver‐body weight ratio was moderately diminished in
old rats. In addition, elderly animals exhibited certain decline in liver
function as suggested by reductions in albumin levels and bile pro-
duction, although no significant differences in transaminases (as a
marker of liver cell injury) were observed. Evaluation of plasma lipids
revealed an increase in cholesterol and LDL cholesterol, without sig-
nificant changes in HDL cholesterol, triglycerides, and free fatty
acids. Moreover, aged rats had higher hepatic lipid accumulation as
compared to young rats by oil red O staining. Hepatic malondialde-
hyde (MDA) in old rats was elevated, suggesting an increase in
oxidative stress secondary to lipid peroxidation process.
As expected, analysis of senescence markers exhibited differences
between young and old animals (Supporting Information Figure S1).
P16, a protein involved in cell cycle regulation, was up‐regulated in
liver tissue and in LSEC freshly isolated from aged rats. SIRT1, an
enzyme related with longevity, was decreased in the aged liver. At last,
we also observed hepatic telomere length attrition in old animals.
2.2 | Aged animals present mild hepatic
microcirculatory dysfunction
When compared to young animals, old rats exhibited significantly higher
hepatic vascular resistance (HVR) in vivo, associated with a reduction in
liver perfusion, altogether leading to a moderately increased portal pres-
sure (PP), without meeting criteria for portal hypertension (Figure 1).
Mean arterial pressure was also significantly elevated, with no signifi-
cant changes in heart rate (308 ± 9 vs. 319 ± 13 bpm).
Ex vivo perfusion experiments analyzing the liver endothelial‐de-
pendent vasodilatory capacity showed no significant differences
between groups (data not shown).
Mechanisms responsible of the observed age‐associated
increased HVR were investigated in succeeding experiments.
2.3 | Aging is associated with mild hepatocyte
injury and dysfunction
Liver architecture was overall preserved in aged animals (Supporting
Information Figure S2); however, evaluation of the severity of
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hepatic injury using a histological damage score revealed mild liver
dysfunction in aged rats in comparison with young animals (Support-
ing Information Table S1). Indeed, injury analysis showed differences
between groups in all of the evaluated parameters including cyto-
plasmic vacuolation, nuclear pyknosis, cytoplasmic hypereosinophilia,
loss of intercellular borders, necrosis, neutrophil infiltration, and fat
accumulation. Ultrastructural analysis of liver damage using transmis-
sion electron microscopy (TEM) evidenced a decrease in the number
of sinusoids with no changes in other parameters. In addition, aged
rats showed higher hepatic cell death as demonstrated by the
TUNEL staining (Supporting Information Figure S3a), with no signifi-
cant changes in apoptotic proteins c‐caspase‐3 and BAD (data not
shown).
Liver tissue analyses were complemented examining the pheno-
type of hepatocytes freshly isolated from both groups of animals
(Supporting Information Figure S3b–d). In agreement with the in vivo
biochemical parameters, aged hepatocytes exhibited slight but not
significant lower urea and albumin synthetic capacity. This was asso-
ciated with deregulation in different specific markers including Oct1
and Mrp3, with no differences in Mrp2 or HNF4α. At last, hepato-
cyte cytochrome P4503A4 activity tended to be higher in aged ani-
mals.
2.4 | The aged hepatic endothelium is
pseudocapillarized and procontractile
Analysis of the liver sinusoid using scanning electron microscopy
confirmed pseudocapillarization of aged LSEC in this experimental
model of aging. As seen in Figure 2a, fenestrae porosity was mark-
edly diminished in the aged hepatic sinusoid. In accordance, aged liv-
ers exhibited reduced expression of VEGFR2, a protein involved in
fenestrae formation and maintenance, and CD32b, a well‐established
marker of LSEC differentiation (Figure 2b,c).
Intrahepatic neovascularization analysis did not show differences
between groups (Figure 2d). Nevertheless, the number of sinusoids
seemed to be decreased in aged livers (Figure 2e), which correlates
with the reduced CD32b expression described above.
Detrimental effects of aging on LSEC phenotype were not lim-
ited to markers of capillarization, but included loss of vasodilatory
capacity. Indeed, aged livers presented reduced eNOS and p‐eNOS
protein expression (Figure 2f,g), associated with a 45% reduction in
the NO‐secondary messenger cGMP (Figure 2h).
Analysis of primary LSEC confirmed a remarkable dysfunction of
cells isolated from aged animals (Figure 3). Although we did not
observe significant changes in mRNA expression of eNOS, ED1, and
CD31, aged LSEC showed alterations in angiocrine, inflammatory,
scavenging, vasodilatory, and oxidative stress pathways. In fact,
endothelial angiocrine molecules seemed to be decreased in aged
LSEC, and the expression of different proinflammatory cytokines
was up‐regulated. The scavenger receptor stabilin‐2 was decreased
in aged LSEC. Moreover, p‐eNOS expression and NO bioavailability
were reduced in aged LSEC in comparison with cells isolated from
young animals. In addition, aged LSEC displayed significantly more
mitochondrial oxidative stress, alongside reduced expression of the
anti‐oxidant enzyme HO‐1.
2.5 | Aged hepatic stellate cells are spontaneously
activated
HSC phenotype was characterized both in liver tissue and freshly iso-
lated cells (Figure 4). Analysis using TEM revealed that aged livers
exhibit a nonsignificant increase in the number of stellate cells with
higher number of intracellular lipid droplets in comparison with young.
A trend for increased HSC in aged livers was supported by incre-
mented desmin protein expression and significant increase in the pro-
liferative HSC‐related growth factor PDGFRβ. In addition, aging was
associated with slight, but significant, activation of HSC as demon-
strated by increments in the mRNA and protein expression of differ-
ent activation markers including α‐SMA, collagen1α1, collagen1α2,
PDGFRβ, and p‐moesin, together with changes in some matrix remod-
eling genes including TIMP‐2 and MMP9. We observed a moderate
but not significant increase in cellular and mitochondrial superoxide
levels in aged HSC in comparison with young HSC. In an interesting
manner, analysis of vitamin A metabolism pathways showed alter-
ations in aged livers; indeed, PNPLA3 expression seemed to be
increased while CRBP‐1 protein levels were diminished.
TABLE 1 Baseline characteristics and biochemical parameters of
3 months young and 20 months old rats
3 months
young
20 months
old
%
change p‐value
Body weight (g) 380 ± 9 678 ± 22 +78 <0.001
Liver (g) 9.9 ± 0.3 15.3 ± 0.4 +54 <0.001
Liver‐body weight
ratio (%)
2.6 ± 0.1 2.4 ± 0.1 −8 0.07
AST (U/L) 119.6 ± 12.2 113.2 ± 8.5 −5 >0.20
ALT (U/L) 48.9 ± 3.0 54.9 ± 6.1 +12 >0.20
Bile production (µl/
min*100 g bw)
72.6 ± 6.8 31.7 ± 9.2 −56 <0.001
Albumin (mg/dl) 26.8 ± 0.5 24.9 ± 0.5 −7 <0.001
Plasma cholesterol
(mg/dl)
52.1 ± 2.0 88.5 ± 8.8 +69 <0.001
Plasma LDL
cholesterol (mg/dl)
24.3 ± 2.5 58.4 ± 5.4 +140 <0.001
Plasma HDL
cholesterol (mg/dl)
16.3 ± 0.7 19.5 ± 2.2 +19 >0.20
Plasma triglycerides
(mg/dl)
57.8 ± 9.1 53.5 ± 7.9 −7 >0.20
Plasma FFA (mg/dl) 662 ± 127 578 ± 99 −12 >0.20
Oil red O staining
(%)
1.00 ± 0.18 5.31 ± 1.10 +431 <0.001
MDA (nmol/mg
protein)
0.86 ± 0.23 2.70 ± 1.00 +213 0.09
LPS (EU/ml) 0.88 ± 0.05 1.28 ± 0.11 +45 0.02
Note. Data expressed as mean ± SEM (n = 12 each group) AST: aspartate
transaminase; ALT: alanine transaminase; FFA: free fatty acids; MDA:
malondialdehyde; LPS: lipopolysaccharide.
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2.6 | The aged hepatic sinusoid is in a moderate
proinflammatory state
Characterization of the inflammatory status of the liver evidenced that
the aged hepatic sinusoid is rather proinflammatory as suggested by
elevated presence and activity of infiltrated myeloid cells including neu-
trophils, increased amount of CD68‐positive macrophages, and dimin-
ished presence of CD163‐positive cells (Figure 5a–c).
When we further analyzed the phenotype of freshly isolated
aged KC, we observed an increase in the inflammatory cytokine
IL‐6, a key driver of liver regeneration, infection defense, and reg-
ulation of metabolic functions (Wuestefeld et al., 2013) without
changes in the mRNA expression of other inflammatory molecules
(Figure 5d).
2.7 | Bacterial translocation and intestinal
inflammation are not affected in elderly rats
In comparison with young rats, aged animals did not present discrep-
ancies in gut bacterial translocation to mesenteric lymph nodes,
feces bacterial load, nor in the expression of the cytokines IFN‐γ,
TNFα, and IL17α measured in the ileum (data not shown). In
contrast, a minor increase in LPS plasmatic levels was observed in
aged rats (Table 1).
2.8 | The aged human liver displays similar features
of a dysfunctional sinusoid
Characterization of the liver sinusoid in young and old human tissues
corroborated most of the molecular changes observed in the animal
model (Figure 6). Indeed, aged livers exhibited features of LSEC de‐
differentiation as suggested by significant reductions in angiocrine
and vasodilatory gene expression levels, together with partial activa-
tion of HSC (Supporting Information Figure S4). As expected, lipid
metabolism and senescence pathways were increased in aged
patients.
3 | DISCUSSION
The socioeconomic and medical care improvements occurring during
the last decades have led to a relevant increase in the elderly, espe-
cially in developed countries (He et al., 2016). Therefore, it is critical
to understand the molecular basis of aging and to identify possible
approaches for therapeutic intervention in case major abnormalities
F IGURE 1 Hepatic and systemic
hemodynamic of 3 months young and
20 months old rats. (a) Mean arterial
pressure (MAP), (b) portal pressure (PP), (c)
portal blood flow (PBF), and (d) hepatic
vascular resistance (HVR) determined in
3 months young and 20 months old rats.
n = 12 per group. Results represent
mean ± SEM
F IGURE 2 Endothelial dedifferentiation in the aged liver. The following markers of sinusoidal endothelial phenotype were analyzed in liver
tissue from young and aged rats. (a) Representative scanning electron microscopy images and quantification of porosity, fenestration
frequency, and fenestration diameter. (b) VEGFR2 protein expression normalized to GAPDH. (c) Representative images of CD32b
immunohistochemistry and corresponding quantification. (d) Representative images of CD31 immunohistochemistry and corresponding
quantification. (e) Representative transmission electron microscopy images and quantification of numbers of sinusoids. (f) Representative
images of eNOS immunohistochemistry and corresponding quantification. (g) Representative western blots of eNOS and p‐eNOS, and protein
quantification normalized to GAPDH. (h) Levels of cyclic GMP. n = 3 (a and e) and n = 12 (other panels) per group. Results represent
mean ± SEM. All images 400x, scale bar=50 μm
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are detected (Longo et al., 2015; Mitchell, Morten, Longo, & Cabo,
2015). Although previous studies described the impact of aging on
the vasculature of different territories, in the specific field of Hepa-
tology, very little is known about the liver microcirculatory function
and the molecular status of hepatic sinusoidal cells in aging (Le Cou-
teur & McLean, 1998; Le Couteur et al., 2001).
In the present study, we demonstrate for the first time that
healthy aged rats exhibit a significant increase in the hepatic vas-
cular resistance, which leads to reduced liver perfusion and to a
mo‐derate increment in portal pressure. Although a reduction in
portal blood inflow was previously reported in humans and
rodents (Vollmar et al., 2002), we herein describe a deregulation
in the intra‐hepatic vascular system due to diverse molecular
changes in the cells of the hepatic sinusoid, together with deterio-
ration in hepatocyte function.
Analysis of hepatocytes revealed mild liver dysfunction in aged
animals, which could likely be a consequence of altered oxygen and
nutrient supply following the alterations in the vascular system. We
observed a reduction in the liver‐body weight ratio, which was
accompanied by a significant decline in synthetic and detoxifying
capabilities as demonstrated by reduced bile formation and decreased
urea and albumin synthesis, together with dysfunctional expression
of hepatocyte transporters. These findings agree with previous
reports (Le Couteur & McLean, 1998; López‐Otín, Blasco, Partridge,
Serrano, & Kroemer, 2013; Tietz, Shuey, & Wekstein, 1992), alto-
gether suggesting a decrease both in the amount and functional
capacity of hepatocytes in aging, therefore advising a potential
enhanced susceptibility to secondary insults such as ischemia/reperfu-
sion or drug‐induced liver injury. From a clinical perspective, it is
important to note that these events are especially common in elderly
population, which have the higher prevalence of circulatory diseases
and receive multiple medications with potential hepatotoxicity.
Underlying mechanisms explaining hepatocyte dysfunction may
relate to adaptations following vascular dysfunction, to other age‐
derived intracellular deregulation, or to cell senescence per se.
Senescence, a cellular mechanism imposed by natural exhaustion of
cell cycle or by stress‐induced signals, was evident in aged animals
as demonstrated by up‐regulation in p16 along with a reduction in
telomere length and SIRT1 protein. In addition, we observed an
increase in hepatic oxidative stress, with multiple harmful conse-
quences, that may derive from an imbalance between pro‐ and anti‐
oxidants, together with increased hepatic lipid content, a well‐known
source of cellular oxidative stress. In an important way, oxidative
stress could also contribute to potentiate the senescence pathways,
and vice versa, thus creating a deleterious vicious cycle in the aged
liver (Jin, Iakova, Jiang, Medrano, & Timchenko, 2011; Sharpless &
De Pinho, 2004).
Characterization of liver microcirculatory dysfunction in aged ani-
mals confirmed LSEC “pseudo‐capillarization,” which was defined by
the decrease in the number and size of fenestrae (Le Couteur et al.,
2001). Further analysis revealed a global deregulation in the hepatic
endothelial phenotype in aging as demonstrated by significant
decrease in key vasodilatory pathways, including nitric oxide and
heme oxygenase, increment in intracellular inflammation and oxidative
stress, and reduction in the expression of functional and angiocrine
markers such as stabilin‐2, CD32b (Xie et al., 2013), and VEGFR2 (Car-
penter et al., 2005). Reduction in intrahepatic nitric oxide availability is
of relevance considering its importance modulating the vascular tone
(Gracia‐Sancho, Maeso‐Diaz, Fernandez‐Iglesias, Navarro‐Zornoza, &
Bosch, 2015; Hori, Wiest, & Groszmann, 1998), exerting anti‐inflam-
matory effects (Iwakiri & Kim, 2015), and maintaining neighboring cells
phenotype (Marrone et al., 2016; Xie et al., 2013). Reduced nitric
oxide bioavailability might, at least in part, derive from diminished
eNOS activity, which may be due to reduced VEGF‐p‐eNOS pathway
(Kroll & Waltenberger, 1998), and from increased scavenging due to
elevated oxidative stress (Gracia‐Sancho et al., 2008). An additional
mechanism contributing to VEGF‐p‐eNOS pathway depletion may be
the increase in the senescence marker p16, which exerts an inhibitory
effect on VEGF (Kawagishi et al., 2010). Nevertheless, a previous
study reported no changes in hepatic VEGF expression in aging (Le
Couteur et al., 2007). Therefore, this issue would require further
investigation to confirm the current findings.
Similar to nitric oxide, the observed diminution in HO‐1 expres-
sion in the aged endothelium may contribute to the increased HVR
(Van Landeghem et al., 2009). Altogether our results strongly suggest
that vasodilatory pathways in LSEC are profoundly affected by age
and this might be one of the mechanisms responsible of aged‐associ-
ated increase in HVR.
A previous report described increased number of fatty HSC in
the aged liver (Warren et al., 2011); however, no comprehensive
analysis of stellate cells phenotype in aging has been conducted.
Herein, we confirm lipid accumulation within aged HSC and addi-
tionally describe increments in other mediators of HSC activation
including intracellular oxidative stress and p16 (Bataller et al., 2003).
In fact, analysis of cellular phenotype revealed a slight, but signifi-
cant, activation of HSC, supported by increments in different activa-
tion markers including α‐SMA or collagen I. Underlying mechanisms
explaining HSC activation in aging revealed no modification in differ-
ent proinflammatory mediators including TLR4, NFκB, and TGFβ
(data not shown), but interestingly suggested alterations in retinoid
F IGURE 3 LSEC phenotype in aged livers. The phenotype of LSEC freshly isolated from aged and young rats was characterized as follows.
(a) mRNA expression of eNOS, ED1, and CD31. (b) mRNA expression of HGF, Wnt2, and Hamp. (c) mRNA expression of TNF‐α, IL‐1, and IL‐6.
(d) Representative western blot of stabilin‐2 normalized to GAPDH. (e) Representative western blots of eNOS and p‐eNOS, normalized to
GAPDH. (f) Representative images of nitric oxide bioavailability using DAF‐FM staining (green fluorescence) and corresponding quantification.
(g) Levels of O2
.- (red fluorescence) determined using DHE. (h) Representative images of mitochondrial O2
.- measured using mitosox (red
fluorescence) and corresponding quantification. (i) HO‐1 protein expression normalized to GAPDH. n = 6 per group. Results represent
mean ± SEM
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F IGURE 4 Effects of aging on HSC phenotype. The phenotype of HSC was characterized in aged and young rats as follows. (a)
Quantification of HSC abundance and intracellular lipid droplets in livers using transmission electron microscopy. (b) Representative images of
fibrotic content, measured as positive, are for Masson’s trichromic, α‐SMA, and desmin with their corresponding quantifications. (c) α‐SMA
protein expression in total liver tissue, normalized to GAPDH. (d) p‐moesin protein expression in total liver tissue, normalized to total moesin.
(e) Expression of α‐SMA, collagen1α1, collagen1α2, and PDGFRβ in freshly isolated HSC. (f) Expression of TIMP1, TIMP2, MMP2, and MMP9
in freshly isolated HSC. (g) Representative images of O2
.- levels in primary HSC (red fluorescence) and corresponding quantification. (h)
Mitochondrial O2
.- levels (red fluorescence) determined in primary HSC. (i) Expression of PNPLA3 in total liver tissue. (j) CRBP1 protein
expression in total liver tissue, normalized to GAPDH. n = 3 (a), n = 12 (b–d, i–j), and n = 6 (e–h) per group. Results represent mean ± SEM. All
images 400×, scale bar = 50 μm
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metabolism and breakdown. In fact, aged livers exhibited down‐regu-
lated CRBP‐1 together with over‐expressed PNPLA3, which have
been associated with HSC activation and susceptibility to develop
steatohepatitis (Bruschi et al., 2017; Uchio et al., 2002).
Very few data regarding inflammation and KC phenotype in
aging are available, and the data are inconclusive. For instance, while
one study reported that KC lose their phagocytic capacity with aging
(Brouwer & Knook, 1983), a subsequent study reported increased
phagocytic activity in KC from aged animals (Hilmer, Cogger, & Le
Couteur, D. G., 2007). In our evaluation, we noticed an increase in
the recruitment of proinflammatory cells with a concomitant incre-
ment in inflammatory markers, altogether suggesting that aging may
F IGURE 4 Continued
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promote a moderate proinflammatory status in the liver. Kupffer
cells isolated from aged rats displayed high IL‐6 levels, which could
possibly reflect beneficial effects of IL‐6 on liver regeneration,
infection defense, and regulation of metabolic functions (Schmidt‐
Arras & Rose‐John, 2016), while traditional “polarization markers” of
hepatic macrophages (Krenkel & Tacke, 2017) were not dramatically
F IGURE 5 Innate immune cell activation and inflammation in aging. (a) Representative images of neutrophil immunofluorescence in liver
tissue (MPO in green, histone 2B in red, nuclei in blue). Left, neutrophil infiltration measured as MPO‐positive cells. Right, analysis of hepatic
neutrophil extracellular traps (NETs) determined as colocalization of MPO and histone 2B. (b) Representative images of CD68
immunofluorescence in liver tissue and corresponding quantification. (c) Representative images of CD163 immunohistochemistry in liver tissue
and its quantification. (d) Expression of TNF‐α, iNOS, IL‐6, Mrc1, Arg1, and IL‐10 in Kupffer cells freshly isolated from young and old rats.
n = 12 (a‐c) and n = 6 (d) per group. Results represent mean ± SEM. All images 400×, scale bar = 50 μm
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altered. However, given the complexity of inflammation and immune
cell subsets, further investigations are required to define, which
inflammatory processes are functionally relevant during aging.
The translocation of bacterial products from the gut is the conse-
quence of intestinal barrier disruption and may lead to bacterial
infection and have consequences in terms of liver and systemic
inflammation and HSC activation. Considering the hemodynamic and
inflammatory changes observed in aged animals, we aimed at analy‐
zing bacterial translocation, fecal bacterial load, intestinal inflamma-
tion, and endotoxemia in old rats. In an interesting manner, these
analyses revealed no significant differences in most of these parame-
ters when comparing both groups of rats, except for LPS plasmatic
levels that were increased in aged rats. We therefore cannot discard
that the observed minimal aged‐related endotoxemia may contribute
to the abnormalities of sinusoidal cells.
At last, and although an undeniable degree of heterogeneity was
found in each group analyzed, characterization of liver biopsies from
healthy young and old humans confirmed the overall trend of path-
way deregulation, therefore suggesting that sinusoidal vulnerability
hereby described in old rats is also of relevance in human aging.
Many efforts are currently being directed toward the development
of novel therapeutic approaches for portal hypertension (Gracia‐Sancho
et al., 2015). Most preclinical studies on the effects of different sub-
stances and drugs on the liver circulation have been conducted in young
animals. Our current work revealed striking differences between young
and aged liver, including alterations in vasoactive pathways, indicating
that studies performed in young animals may not entirely reflect what
should be expected from the cli‐nical use of most interventions, as
vasoactive drugs are and will be mainly prescribed in the elderly.
We are aware that our study is descriptive in nature. However,
this work represents an important cornerstone characterization of
liver aging. While single variables have been examined previously, no
preceding report fully described the liver microcirculatory phenotype
in a preclinical model of healthy aging, additionally including valida-
tion in human samples. These data provide important evidence for
the changing biology of the liver in aging and create new research
avenues to comprehend the effects of acute or chronic liver injury in
the elderly. It is important to acknowledge that aged animals exhib-
ited some degree of steatosis; therefore, part of the results could be
attributable to intracellular fat instead of age. Nevertheless, a
F IGURE 6 Aged‐related changes in the human liver. Gene expression analysis in healthy young and old human livers. Data expressed as
fold enrichment (log2) old relative to young (0.0). The fold enrichments are plotted using positive values for transcripts that are increased or
using negative values for transcripts that are decreased in old humans. *p‐value <0.05, n = 14 young and 13 old livers. Clinical characteristics
of donors are described in Supporting Information Table S2
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subanalysis of animals without evidence of significant steatosis con-
firmed the same hemodynamic and molecular results than in the
group of animals exhibiting steatosis (data not shown), therefore
ensuring that the results of this study describe the effects of aging
per se on liver microcirculatory phenotype.
In conclusion, the present study demonstrates for the first time
that aging is accompanied by significant liver sinusoidal deregulation,
both in rodents and humans, suggesting sinusoidal vulnerability in
front of subsequent chronic or acute injuries.
4 | EXPERIMENTAL PROCEDURES
A complete description of Materials and Methods can be found in
Appendix S1.
4.1 | Animal model
Male Wistar rats at the age of 20 months old were used to evaluate
aging and compared to young animals of 3 months old (n = 12 animals
per group) (Steppan et al., 2014; Wang, Wehling‐Henricks, Samengo, &
Tidball, 2015). Animals were kept in environmentally controlled animal
facilities at IDIBAPS. All procedures were approved by the Laboratory
Animal Care and Use Committee of the University of Barcelona and
were conducted in accordance with the European Community guideli-
nes for the protection of animals used for experimental and other scien-
tific purposes (EEC Directive 86/609).
4.2 | In vivo hemodynamic measurements
Mean arterial pressure (MAP), portal pressure (PP), and portal blood
flow (PBF) were measured in old and young rats using micro-
catheters and flow probes (Marrone et al., 2015). Hepatic vascular
resistance (HVR) was calculated as PP/PBF.
4.3 | Hepatic cells isolation
Hepatocytes, Kupffer cells (KC), liver sinusoidal endothelial cells
(LSEC), and hepatic stellate cells (HSC) were isolated using well‐
established protocols (De Mesquita et al., 2017; Gracia‐Sancho et al.,
2007). Only highly pure and viable cells were used.
4.4 | Electron microscopy
Liver sinusoidal ultrastructure was characterized using electron
microscopy as previously described (Le Couteur et al., 2001).
4.5 | Histological analysis
Liver samples were fixed in 10% formalin, embedded in paraffin, sec-
tioned, and slides were stained with hematoxylin and eosin (H&E) to ana-
lyze the hepatic parenchyma (Hide et al. 2016), with Masson’s trichrome
for liver fibrosis evaluation (Gracia‐Sancho et al., 2011), with oil red O
for lipid quantification or with corresponding antibodies for immunohis-
tochemistry (IHC) or immunofluorescence (IF; Marrone et al., 2015).
4.6 | Cell death
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) was performed in deparaffinized liver sections using an In
Situ Cell Death Detection Kit (Roche Diagnostics, Sant Cugat del
Valles, Barcelona, Spain) according to the manufacturer’s instructions
(Hide et al., 2014).
4.7 | Nitric oxide and superoxide determinations
Levels of cGMP, marker of nitric oxide bioavailability, were analyzed
in liver homogenates using an enzyme immunoassay following manu-
facturer instructions (Cayman Chemical Co., Ann Arbor, MI) (Gracia‐
Sancho et al., 2008). In situ superoxide and nitric oxide levels in cells
were assessed with the oxidative fluorescent dye dihydroethidium
(DHE 10 µM; Molecular Probes Inc., Eugene, OR) or with 4‐amino‐5‐
methylamino‐2′,7′‐difluorofluorescein diacetate (DAF‐FM‐DA 10 µM;
Molecular Probes Inc.), respectively, as described (Hide et al., 2014).
Fluorescence images were obtained with a fluorescence microscope
(Olympus BX51, Tokyo, Japan), and quantitative analysis of at least
20 images per condition containing equivalent number of cells was
performed with Image J 1.44m software.
4.8 | Human liver samples collection for mRNA
analysis
Two‐by‐two cm wedge sharp cuts were obtained from the liver from
donors after brain death without the use of electrocautery, once the
donor next of kin provided written informed consent (Document R‐
DON‐049 02/15). Biopsies were immediately stored in diethyl pyro-
carbonate solution, a nuclease inhibitor, for mRNA analysis. Ethics
Committee of the Barcelona Hospital Clinic approved the experimen-
tal protocol (HCB/2011/6499). RNA extraction and gene expression
analysis were performed as described in Supporting Information
Appendix S1 (Experimental Procedures). Experimental groups were
defined considering donors’ age: young (n = 14, mean age
28 ± 2 years old, range 19–38) and old (n = 13, mean age 76 ± 0.8,
range 71–85). No differences in other clinical parameters were found
comparing groups (Supporting Information Table S2).
4.9 | Statistical analysis
Statistical analysis was performed with the SPSS for Windows statis-
tical package (IBM, Armonk, New York, USA). All results are
expressed as mean ± standard error of the mean (SEM). Comparisons
between groups were performed with Student's t test. Differences
were considered significant at a p value <0.05.
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